Business Description
Y-Biologics Inc
ISIN : KR7338840002
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 19.96 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 9.94 | |||||
Beneish M-Score | -4.77 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 33.4 | |||||
3-Year EBITDA Growth Rate | -8.3 | |||||
3-Year EPS without NRI Growth Rate | -8.2 | |||||
3-Year FCF Growth Rate | 17.4 | |||||
3-Year Book Growth Rate | 9.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.53 | |||||
9-Day RSI | 46.79 | |||||
14-Day RSI | 45.38 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.05 | |||||
Quick Ratio | 6.05 | |||||
Cash Ratio | 5.66 | |||||
Days Sales Outstanding | 25.83 | |||||
Days Payable | 2.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9 | |||||
Shareholder Yield % | -9.74 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 76.67 | |||||
Operating Margin % | -208.41 | |||||
Net Margin % | -460.13 | |||||
FCF Margin % | -194.99 | |||||
ROE % | -130.27 | |||||
ROA % | -76.43 | |||||
ROIC % | -48.39 | |||||
ROC (Joel Greenblatt) % | -216.87 | |||||
ROCE % | -120.42 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 27.97 | |||||
PB Ratio | 5.77 | |||||
Price-to-Tangible-Book | 5.86 | |||||
EV-to-EBIT | -6.01 | |||||
EV-to-EBITDA | -6.59 | |||||
EV-to-Revenue | 27.6 | |||||
EV-to-FCF | -14.16 | |||||
Price-to-Net-Current-Asset-Value | 9.2 | |||||
Price-to-Net-Cash | 10.06 | |||||
Earnings Yield (Greenblatt) % | -16.64 | |||||
FCF Yield % | -6.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Y-Biologics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 4,077.165 | ||
EPS (TTM) (â‚©) | -1473 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 45.38 | ||
14-Day ATR (â‚©) | 655.746662 | ||
20-Day SMA (â‚©) | 9013 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (â‚©) | 8210 - 23800 | ||
Shares Outstanding (Mil) | 14.76 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Y-Biologics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Y-Biologics Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Y-Biologics Inc Frequently Asked Questions
What is Y-Biologics Inc(XKRX:338840)'s stock price today?
When is next earnings date of Y-Biologics Inc(XKRX:338840)?
Does Y-Biologics Inc(XKRX:338840) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |